Doctors Note Logo

Published on: 10/1/2026

Can Zyn cause stomach cancer? What is actually known

There is currently no scientific evidence proving that Zyn or other nicotine pouches cause stomach cancer, largely because these tobacco-leaf-free products are too new for long-term cancer research to exist. Studies on traditional smokeless tobacco and Swedish snus, which carry higher levels of carcinogenic nitrosamines, suggest links to oral, esophageal, and pancreatic cancers, while the findings on gastric cancer specifically remain limited and inconsistent

answer background

Explanation

Can Zyn Cause Stomach Cancer? What We Actually Know

Zyn nicotine pouches have grown in popularity as a smokeless, “tobacco-free” alternative for adults seeking nicotine without the smoke, spit or odor of cigarettes and chewing tobacco. With any nicotine product, questions arise about long-term safety and cancer risk. In particular, some users wonder: can Zyn cause stomach cancer?

Based on credible resources—peer-reviewed studies, government agencies and independent experts—here’s what’s known right now.


What Is Zyn?

  • Nicotine source: Zyn pouches contain pharmaceutical-grade nicotine extracted from tobacco, but they do not include tobacco leaf or stem.
  • Other ingredients: food-grade flavorings, pH adjusters (to optimize nicotine absorption), plant-based fibers and a small amount of sweetener.
  • How they’re used: placed between gum and lip, where nicotine is absorbed through the oral mucosa.

Because Zyn pouches don’t produce smoke, they lack tar and carbon monoxide—two of the main cancer-causing culprits in cigarettes.


Key Risk Factors for Stomach Cancer

Before diving into Zyn specifically, it helps to understand established causes of gastric (stomach) cancer:

  • Helicobacter pylori infection
    A common bacterial infection that causes chronic inflammation and ulcers.
  • Dietary factors
    High intake of smoked, salted or pickled foods; low fruits and vegetables.
  • Tobacco smoking
    Inhaled tobacco smoke increases risk; secondhand smoke also contributes.
  • Heavy alcohol use
    Especially when combined with smoking.
  • Family history/genetics
    Certain inherited syndromes raise risk.
  • Previous stomach surgery or chronic gastritis
    Long-term inflammation can lead to cellular changes.
  • Obesity
    May increase risk of cancers of the upper stomach.

Nicotine use via smoking clearly contributes to stomach and other cancers, but the role of nicotine on its own is far less certain.


Nicotine and Cancer: The Official View

IARC Classification

  • The International Agency for Research on Cancer (IARC) has not classified nicotine itself as a carcinogen.
  • IARC does classify tobacco smoke and certain smokeless tobacco products as carcinogenic, largely due to hundreds of other chemicals in those products.

Nicotine’s Biological Effects

  • In laboratory studies, nicotine can:

    • Promote blood vessel growth (angiogenesis).
    • Encourage cell proliferation.
    • Potentially aid in tumor progression if cancer is already present.
  • Crucial point: Promoting existing cancer cells in a petri dish is not the same as causing cancer in a healthy human.


Smokeless Tobacco vs. Nicotine Pouches

Smokeless Tobacco (e.g., Chewing Tobacco, Snus)

  • Contains tobacco leaf, which has tobacco-specific nitrosamines (TSNAs)—some of the most potent carcinogens in tobacco.
  • Linked to increased risk of oral, esophageal and pancreatic cancers.

Nicotine Pouches (e.g., Zyn)

  • Claim to have non-tobacco nicotine and far lower TSNA levels than even Swedish snus.
  • Independent lab tests show TSNAs in Zyn are often near the lower limit of detection—but not zero.
  • No long-term human studies exist to measure cancer outcomes from exclusive nicotine pouch use.

What Does the Research Say?

  1. Lack of Direct Studies
    No published epidemiological studies have linked Zyn or similar pouches to stomach cancer in humans. These products are too new for decades-long follow-up.

  2. Animal and Cell Studies

    • High doses of nicotine in animals have sometimes shown promotional effects on tumors started by other carcinogens.
    • These studies use nicotine levels much higher than a typical pouch user ingests.
  3. Nicotine Replacement Therapy (NRT) Insights

    • Decades of data on nicotine gum, patch and inhaler show no clear increase in cancer risk from nicotine alone.
    • NRT products deliver nicotine without TSNAs, and users typically taper off within months.
  4. TSNA Exposure

    • Zyn’s low TSNA content suggests a substantially lower theoretical risk compared with traditional smokeless tobacco.
    • Even so, “very low” is not the same as “zero,” and the effect of chronic exposure is unknown.

Bottom Line: Can Zyn Cause Stomach Cancer?

  • Current evidence: No direct link between Zyn (or other nicotine pouches) and stomach cancer.
  • Nicotine itself: Not classified as a carcinogen, though it may promote tumor growth in certain lab settings.
  • TSNAs and impurities: Present at very low levels in Zyn; long-term impact not yet studied.
  • Overall risk: Likely much lower than smoking and conventional smokeless tobacco, but not proven risk-free.

What You Can Do Today

  1. Monitor symptoms
    Any persistent abdominal discomfort, unexplained weight loss or digestive changes warrant evaluation. You might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get guidance on next steps.

  2. Discuss with your doctor
    If you have concerns about nicotine pouch use—or any symptoms that could be serious—talk with a healthcare professional. Only they can interpret your individual risk factors.

  3. Consider risk reduction

    • If you’re using Zyn pouches as a smoking alternative, recognize it’s likely safer than continuing to smoke.
    • If you’re not a smoker, weigh whether nicotine use is right for you at all.
  4. Stay informed
    New research may emerge in the coming years. Bookmark credible sources like the National Cancer Institute (NCI) or IARC for updates.


When to Seek Immediate Help

Stomach cancer can present subtly. Seek medical attention if you experience:

  • Blood in vomit or stool
  • Trouble swallowing
  • Persistent vomiting
  • Unexplained weight loss
  • Severe or persistent abdominal pain

For any life-threatening or serious concerns, please speak to a doctor right away or call emergency services.


Final Thoughts

At present, there is no direct evidence that Zyn nicotine pouches cause stomach cancer. However, absence of proof is not proof of absence. Nicotine’s effects on cell biology and trace TSNAs in pouches leave unanswered questions about very long-term use. If you have concerns—especially if you experience digestive symptoms—please discuss them with your doctor and consider a free, online symptom check with the Ubie Symptom Checker.

Your health decisions deserve both the best available evidence and personalized medical advice. Stay curious, stay cautious, and stay connected with healthcare professionals.

(References)

  • * Dunham LJ, Snell KC, Stewart HL. Argyrophilic carcinoids in two Syrian hamsters (Mesocricetus auratus). J Natl Cancer Inst. 1975 Feb;54(2):507-13. PMID: 46277.

  • * Singer GM, Taylor HW. Carcinogenicity of N'-nitrosonornicotine in Sprague-Dawley rats. J Natl Cancer Inst. 1976 Dec;57(6):1275-6. doi: 10.1093/jnci/57.6.1275. PMID: 1003559.

  • * Fontham ET, Correa P, Chen VW, Craig JF, Pickle LW, Falk R. Tobacco and cancer. J La State Med Soc. 1988 Apr;140(4):29-30, 35-40. PMID: 3373192.

  • * Staszewski J. [Role of mortality statistics in epidemiological studies of neoplasms in Poland]. Pol Tyg Lek. 1971 Jul 8;26(6):225-7. PMID: 4928054.

  • * Zacho A, Nielsen J, Larsen V. [Consumption of unburned tobacco in patients with cancer of the stomach]. Ugeskr Laeger. 1967 Nov 2;129(44):1470-2. PMID: 5594980.

  • * Kurkalo VK, Vol'Fson NI. [Nicotine stimulation of the carcinogenic effect of N-methyl-N'-nitro-N-nitrozoguanidine]. Vopr Onkol. 1982;28(9):34-8. PMID: 7123880.

  • * Kesh K, Subramanian L, Ghosh N, Gupta V, Gupta A, Bhattacharya S, Mahapatra NR, Swarnakar S. Association of MMP7 -181A→G Promoter Polymorphism with Gastric Cancer Risk: INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB). J Biol Chem. 2015 Jun 5;290(23):14391-406. doi: 10.1074/jbc.M114.630129. Epub 2015 Apr 6. PMID: 25847246; PMCID: PMC4505507.

  • * Tu CC, Huang CY, Cheng WL, Hung CS, Chang YJ, Wei PL. Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment. Tumour Biol. 2016 Jul;37(7):9493-501. doi: 10.1007/s13277-015-4751-x. Epub 2016 Jan 20. PMID: 26790437.

  • * Xu Y, Wang J, He Z, Rao Z, Zhang Z, Zhou J, Zhou T, Wang H. A review on the effect of COX-2-mediated mechanisms on development and progression of gastric cancer induced by nicotine. Biochem Pharmacol. 2024 Feb;220:115980. doi: 10.1016/j.bcp.2023.115980. Epub 2023 Dec 10. PMID: 38081368.

  • * Nadkarni A, Gaikwad L, Sequeira M, Javeri P, Benoy D, Pacheco MG, Velleman R, Murthy P, Naughton F. Behavioral Interventions for Tobacco Cessation in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Nicotine Tob Res. 2025 Mar 24;27(4):575-585. doi: 10.1093/ntr/ntae259. PMID: 39485008; PMCID: PMC11931222.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.